美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70518-2216-0	70518-2216	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20190715	20250331	ANDA	ANDA090622	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE	2 mg/1	30 TABLET in 1 BLISTER PACK (70518-2216-0)
50383-924-93	50383-924	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20100924	20250331	ANDA	ANDA090622	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE	2 mg/1	30 TABLET in 1 BOTTLE (50383-924-93)
0121-2038-30	0121-2038	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20231012	N/A	ANDA	ANDA090622	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE	8 mg/1	30 TABLET in 1 BOTTLE (0121-2038-30)
50090-1571-0	50090-1571	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20141223	N/A	ANDA	ANDA090622	A-S Medication Solutions	BUPRENORPHINE HYDROCHLORIDE	8 mg/1	30 TABLET in 1 BOTTLE (50090-1571-0)
50383-930-93	50383-930	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20100924	20250331	ANDA	ANDA090622	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE	8 mg/1	30 TABLET in 1 BOTTLE (50383-930-93)
0121-1019-30	0121-1019	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride	buprenorphine hydrochloride	TABLET	SUBLINGUAL	20231012	N/A	ANDA	ANDA090622	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE	2 mg/1	30 TABLET in 1 BOTTLE (0121-1019-30)